MEC1 were often higher in the late-stage (Stage VI/III) group in all 3 HNSCC cohorts (Chen’s cohort, GSE41613, TCGA HNSCC) than the early-stage group (Stage I/II) (Fig. 5F). This evidence concerns the gene ATR and head and neck squamous cell carcinoma.